Display options
Cite
Diaz GJ. Basolateral and canalicular transport of xenobiotics in the hepatocyte: A review. Cytotechnology. 2000;34(3):225-35doi: 10.1023/A:1008152205697.
Diaz, G. J. (2000). Basolateral and canalicular transport of xenobiotics in the hepatocyte: A review. Cytotechnology, 34(3), 225-35. https://doi.org/10.1023/A:1008152205697
Diaz, G J. "Basolateral and canalicular transport of xenobiotics in the hepatocyte: A review." Cytotechnology vol. 34,3 (2000): 225-35. doi: https://doi.org/10.1023/A:1008152205697
Diaz GJ. Basolateral and canalicular transport of xenobiotics in the hepatocyte: A review. Cytotechnology. 2000 Nov;34(3):225-35. doi: 10.1023/A:1008152205697. PMID: 19003398; PMCID: PMC3449628.
Copy Download .nbib Format: NLM
Share it on

Cytotechnology. 2000 Nov;34(3):225-35. doi: 10.1023/A:1008152205697.

Basolateral and canalicular transport of xenobiotics in the hepatocyte: A review.

Cytotechnology

G J Diaz

Affiliations

  1. Facultad de Medicina Veterinaria y de Zootecnia, Universidad Nacional de Colombia, Apartado Aéreo 76948, Santafé de Bogotá, D.C., Colombia;, [email protected].

PMID: 19003398 PMCID: PMC3449628 DOI: 10.1023/A:1008152205697

Abstract

The molecular and functional characterization of severalproteins involved in the uptake and excretion of xenobioticsand endogenous compounds in the hepatocyte has been achievedthrough intensive research conducted in the past few years.These studies have lead to the identification of specificmembrane transporters located in the basolateral andcanalicular membrane domains of the hepatocyte. The organicanion-transporting polypeptide (OATP), present in thebasolateral membrane of the hepatocyte, is responsible for thetranslocation of xenobiotics from the sinusoidal space into thehepatocyte. Once inside the cell, unconjugated neutral, anionicand cationic xenobiotics can be secreted into bile by themultidrug-resistance P-glycoprotein 1 (MDR1). Conjugatedxenobiotics (e.g. glucuronides and glutathione conjugates) aresecreted into bile by the canalicular multispecific organicanion transporter (cMOAT). Other transporters play keyphysiological roles, including the basolateral uptake of bilesalts (sodium-taurocholate cotransporter, NTCP) and thesecretion into bile of conjugated and unconjugated bile salts(bile salt export pump, BSEP) and phospholipids (MDR2).Experimental approaches used to investigate the role of thebasolateral and canalicular transporters in the hepatocyte haveincluded both in vivo and in vitro models. Animalmodels lacking canalicular transporters include the;hyperbilirubinemic' rats (Groningen-Yellow (GY), Eisaihyperbilirubinemic (EHB) and TR(-) rats), which aredeficient in the cMOAT protein, and ;knock-out' mice, lackingeither the MDR1 or MDR2 transporter. Although no animal modelsare currently available for the study of basolateraltransporters, their function has been conveniently investigatedthrough heterologous expression in Xenopus laevis oocytesand also with basolateral membrane vesicles isolated fromhepatocytes. The total number of basolateral and canaliculartransport proteins present in the hepatocyte is still unknown,but current knowledge indicates that there are at least fourpresent in the basolateral membrane and five in the canaliculardomain. The present review focuses on the current knowledgeabout the most relevant hepatocyte transporters involved in theuptake of foreign and endogenous compounds from the sinusoidalspace and in their active secretion into bile. The first partof the review deals with the basolateral (sinusoidal) transportof organic anions, and the major basolateral transporters (e.g.NTCP, OATP) are described here, both in terms of their knownbiochemistry and physiology. In the second part of the review,the canalicular (apical) transport of organic anions isdiscussed and the biochemistry and physiological role of MDR1,MDR2, cMOAT and BSEP is described in detail. The concludingremarks point out areas of research that need to be addressedin order to answer important questions that still remainunanswered in this important field of study.

References

  1. Cell. 1994 May 20;77(4):491-502 - PubMed
  2. FEBS Lett. 1998 Aug 14;433(1-2):149-52 - PubMed
  3. Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):4028-33 - PubMed
  4. J Pharm Sci. 1998 Sep;87(9):1025-40 - PubMed
  5. Cancer Res. 1996 Sep 15;56(18):4124-9 - PubMed
  6. Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10346-50 - PubMed
  7. FASEB J. 1997 Jan;11(1):15-8 - PubMed
  8. Pharmacol Ther. 1994 Oct;64(1):77-97 - PubMed
  9. Mol Pharmacol. 1998 Jun;53(6):1068-75 - PubMed
  10. J Mol Med (Berl). 1997 Jun;75(6):420-8 - PubMed
  11. Cytotechnology. 1998 Sep;27(1-3):71-9 - PubMed
  12. FEBS Lett. 1998 Jun 12;429(2):179-82 - PubMed
  13. Nat Genet. 1998 Nov;20(3):233-8 - PubMed
  14. J Biol Chem. 1998 Jan 16;273(3):1684-8 - PubMed
  15. J Clin Invest. 1994 Mar;93(3):1326-31 - PubMed
  16. Cancer Res. 1995 May 15;55(10):2029-34 - PubMed
  17. Science. 1992 Dec 4;258(5088):1650-4 - PubMed
  18. Biochem J. 1999 Mar 1;338 ( Pt 2):393-401 - PubMed
  19. J Pharmacol Exp Ther. 1996 Mar;276(3):891-6 - PubMed
  20. Drug Metab Dispos. 1999 Feb;27(2):161-6 - PubMed
  21. Am J Physiol. 1997 Jan;272(1 Pt 1):G16-22 - PubMed
  22. FASEB J. 1997 Jan;11(1):19-28 - PubMed
  23. Hepatology. 1997 Jun;25(6):1539-42 - PubMed
  24. J Biol Chem. 1998 Apr 17;273(16):10046-50 - PubMed
  25. Cancer Res. 1997 Aug 15;57(16):3506-10 - PubMed
  26. Pharm Res. 1999 Mar;16(3):408-14 - PubMed
  27. Gen Pharmacol. 1996 Dec;27(8):1283-91 - PubMed
  28. J Hepatol. 1996 Nov;25(5):733-8 - PubMed
  29. J Cell Sci. 1994 Apr;107 ( Pt 4):1065-72 - PubMed
  30. Hum Mol Genet. 1998 Feb;7(2):203-7 - PubMed
  31. Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10629-33 - PubMed
  32. N Engl J Med. 1998 Oct 22;339(17):1217-27 - PubMed
  33. Cell. 1993 Nov 5;75(3):451-62 - PubMed
  34. Gastroenterology. 1995 Oct;109(4):1274-82 - PubMed
  35. Science. 1996 Feb 23;271(5252):1126-8 - PubMed
  36. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7735-8 - PubMed
  37. Arch Toxicol. 1998 Dec;72(12):763-8 - PubMed
  38. Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):133-7 - PubMed
  39. J Control Release. 1999 Nov 1;62(1-2):25-31 - PubMed
  40. Biochim Biophys Acta. 1996 Apr 19;1300(2):114-8 - PubMed
  41. J Biol Chem. 1996 Jun 21;271(25):15091-8 - PubMed
  42. J Biol Chem. 1991 Mar 15;266(8):5303-10 - PubMed
  43. Biochim Biophys Acta. 1976 Nov 11;455(1):152-62 - PubMed
  44. Pol J Pharmacol. 1997 Nov-Dec;49(6):387-94 - PubMed
  45. Biochem Biophys Res Commun. 1998 Dec 18;253(2):454-7 - PubMed
  46. Biochim Biophys Acta. 1980 May 27;604(1):27-64 - PubMed
  47. Blood. 2000 Feb 1;95(3):1014-22 - PubMed
  48. Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):282-7 - PubMed
  49. Biochem Biophys Res Commun. 1998 Nov 9;252(1):103-10 - PubMed
  50. J Biol Chem. 1998 Aug 28;273(35):22395-401 - PubMed
  51. Eur J Biochem. 1997 Mar 1;244(2):664-73 - PubMed

Publication Types